共 50 条
- [21] Drug companies are ignoring health crisis in poor countries [J]. BRITISH MEDICAL JOURNAL, 2007, 335 (7630): : 1111 - 1111
- [22] Determining House Prices in Data-Poor Countries: Evidence from Ghana [J]. INTERNATIONAL REAL ESTATE REVIEW, 2019, 22 (04): : 571 - 595
- [24] A comparison of generic drug prices in seven European countries: a methodological analysis [J]. BMC Health Services Research, 17
- [25] Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars [J]. Advances in Rheumatology, 61
- [26] A comparison of generic drug prices in seven European countries: a methodological analysis [J]. BMC HEALTH SERVICES RESEARCH, 2017, 17
- [27] Poor countries press for extension of exemption from drug patents [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
- [29] A COMPARISON OF GDP-ADJUSTED ORPHAN DRUG PRICES IN 12 EUROPEAN COUNTRIES [J]. VALUE IN HEALTH, 2017, 20 (05) : A223 - A223
- [30] Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries [J]. PLOS ONE, 2011, 6 (05):